AJOG MFM/LinkedIn
Dec 26, 2025, 13:09
Postpartum Readmission Rates Linked to Antihypertensive Choice – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
“In a retrospective cohort of individuals with hypertensive disorders of pregnancy, discharge with labetalol rather than nifedipine was independently associated with increased risk of postpartum hospital readmission (9.2% vs 3.9%, P<.001).
Read the full text here.”
Title: Postpartum health-care utilization and blood pressure control by antihypertensive agent in hypertensive disorders of pregnancy
Authors: Carrie Bennett, Lara Lemon, Kripa Venkatakrishnan, Sanjana Ghosh, Hyagriv Simhan, Alisse Hauspurg
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 3, 2026, 12:57Sergei Gorlovetsky: The Invisible Work Breaking Fertility Clinics
-
Apr 3, 2026, 12:50Ting Yuan: Rethinking Oocyte Quality Through Reproducible Patterns
-
Apr 3, 2026, 12:36Asma Khalil: An Incredibly Powerful Podcast Brings Attention to Women’s Fertility Challenges
-
Apr 3, 2026, 12:29Angela Koech: Every 30 Seconds, Africa Loses a Baby to a Preventable Stillbirth
-
Apr 3, 2026, 12:17Sergei Gorlovetsky: AI Support Expands Guidance for IVF Patients at Home
-
Apr 3, 2026, 12:06Thin Womb Lining Doesn’t Have to End Your IVF Dreams – Fertility Plus
-
Apr 3, 2026, 12:04Updated NICE IVF Guidance Contrasts with Declining NHS Support – HFEA
-
Apr 3, 2026, 11:59IVF Remains Safe for Women With a History of Cancer – ESHRE
-
Apr 3, 2026, 11:56Vitamin D Binding Protein and Reproductive Outcomes – Fertility and Sterility